These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28868890)

  • 21. Immunoglobulin (Ig) in multifocal motor neuropathy (MMN): update on evidence for Ig treatment in MMN.
    Léger JM
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):42-4. PubMed ID: 25546756
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case of acute autonomic, sensory and motor neuropathy (AASMN)--less favorable response of the autonomic dysfunctions to IVIg treatment].
    Takahashi T; Tamura M; Chida K; Ogawa K; Ono S; Tsuda H; Suzuki Y; Mizutani T
    Rinsho Shinkeigaku; 2004 Sep; 44(9):643-7. PubMed ID: 15515713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comment: Human papillomavirus vaccination, induced autoimmunity, and neuromyelitis optica.
    Farrell RA
    Neurology; 2012 Jul; 79(3):287. PubMed ID: 22722623
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of severe toxicity during coadministration of vincristine and piperacillin: are drug transporters involved in vincristine hypersensitivity and drug-drug interactions?
    Le Guellec C; Benz-de Bretagne I; Jonville-Bera AP; Tarfaoui N; Andres CR; Gendrot C; Jourdain A
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):e341-3. PubMed ID: 22627576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dramatic response to intravenous immunoglobulins in dysautonomic neurosarcoidosis.
    Grignano E; Mekinian A; Dubourg O; Dhote R; Fain O
    J Clin Neurosci; 2013 Dec; 20(12):1807-8. PubMed ID: 24090517
    [No Abstract]   [Full Text] [Related]  

  • 26. No association of HPV vaccination with serious adverse events.
    Caskey R
    J Pediatr; 2014 May; 164(5):1240. PubMed ID: 24742654
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and perception: What are the greatest enemies of HPV vaccination programmes?
    Bonanni P; Zanella B; Santomauro F; Lorini C; Bechini A; Boccalini S
    Vaccine; 2018 Aug; 36(36):5424-5429. PubMed ID: 28610824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Struggles within Japan's national HPV vaccination: A proposal for future strategy.
    Tanaka Y; Ueda Y; Kimura T
    Hum Vaccin Immunother; 2017 May; 13(5):1167-1168. PubMed ID: 28059676
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination.
    Takahashi Y; Matsudaira T; Nakano H; Nasu H; Ikeda H; Nakaoka K; Takayama R; Oota M
    J Neuroimmunol; 2016 Sep; 298():71-8. PubMed ID: 27609278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review of human papillomavirus vaccine coadministration.
    Noronha AS; Markowitz LE; Dunne EF
    Vaccine; 2014 May; 32(23):2670-4. PubMed ID: 24412351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small fiber neuropathy: a common and important clinical disorder.
    Hoitsma E; Reulen JP; de Baets M; Drent M; Spaans F; Faber CG
    J Neurol Sci; 2004 Dec; 227(1):119-30. PubMed ID: 15546602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus vaccination in HIV-infected women: need for increased coverage.
    Kojic EM; Rana AI; Cu-Uvin S
    Expert Rev Vaccines; 2016; 15(1):105-17. PubMed ID: 26599305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV vaccination and recurrent respiratory papillomatosis.
    Jeyakumar A; Mitchell R
    Otolaryngol Head Neck Surg; 2011 Jan; 144(1):133. PubMed ID: 21493406
    [No Abstract]   [Full Text] [Related]  

  • 34. [HPV vaccination – should/should not?].
    Thomsen AR; Christensen JP
    Ugeskr Laeger; 2015 Aug; 177(18):. PubMed ID: 26324287
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years.
    Einstein MH; Baron M; Levin MJ; Chatterjee A; Edwards RP; Zepp F; Carletti I; Dessy FJ; Trofa AF; Schuind A; Dubin G;
    Hum Vaccin; 2009 Oct; 5(10):705-19. PubMed ID: 19684472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Chesson HW; Curtis CR; Gee J; Bocchini JA; Unger ER;
    MMWR Recomm Rep; 2014 Aug; 63(RR-05):1-30. PubMed ID: 25167164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of HPV vaccination: a FIGO statement.
    Denny L;
    Int J Gynaecol Obstet; 2013 Dec; 123(3):187-8. PubMed ID: 24139200
    [No Abstract]   [Full Text] [Related]  

  • 38. [Possible side effects from HPV vaccination in Denmark].
    Hammer A; Petersen LK; Rolving N; Boxill MF; Kallesøe KH; Becker S; Fredberg U; Sørensen VN; Rask CU; Fink PK; Blaakær J
    Ugeskr Laeger; 2016 Jun; 178(26):. PubMed ID: 27402125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to: HPV vaccine and autoimmunity Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study.
    Hawkes D; Wilkinson W; Dunlop RA
    J Intern Med; 2017 May; 281(5):530-531. PubMed ID: 28295767
    [No Abstract]   [Full Text] [Related]  

  • 40. The new H1N1 and HPV vaccines and old fears.
    Balofsky A; Agmon-Levin N; Shoenfeld Y
    Curr Opin Rheumatol; 2010 Jul; 22(4):431-6. PubMed ID: 20485175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.